Nearly half of adults – 45% – haven’t discussed their sleep health with a healthcare professional, a new survey reveals. This communication gap, particularly pronounced among women, hinders access to specialist care and potentially exacerbates the health consequences of untreated sleep disorders. The findings underscore a critical need for proactive dialogue between patients and providers.
The implications of this silence are far-reaching. Sleep is not merely a period of rest; it’s a fundamental physiological process integral to nearly every system in the body. Chronic sleep deprivation, or even suboptimal sleep quality, is increasingly linked to a cascade of adverse health outcomes, including cardiovascular disease, type 2 diabetes, obesity, mood disorders and a weakened immune response. The failure to address sleep issues proactively represents a significant missed opportunity for preventative medicine and a potential strain on global healthcare resources.
In Plain English: The Clinical Takeaway
- Talk to your doctor about sleep: Don’t assume sleep problems are just a normal part of life. They can be signs of underlying medical conditions.
- Women are disproportionately affected: If you’re a woman experiencing sleep difficulties, be especially proactive in seeking medical advice.
- Sleep specialists can help: If your primary care physician can’t resolve your sleep issues, ask for a referral to a sleep specialist.
The American Academy of Sleep Medicine (AASM) survey, published this week, highlights a concerning disparity in healthcare access. Women are 49% more likely than men (40%) to have *not* discussed their sleep with a healthcare professional. This translates to fewer referrals to sleep specialists – only 9% of women reported such a discussion compared to 21% of men. This gender gap is likely multifactorial, potentially stemming from societal expectations, hormonal fluctuations, and differing symptom presentation. The underlying mechanisms connecting sleep disruption and female reproductive health are currently under intense investigation, with emerging research suggesting a bidirectional relationship mediated by the hypothalamic-pituitary-ovarian (HPO) axis. [1]
Beyond gender, socioeconomic factors also play a role. Individuals from lower socioeconomic backgrounds often face barriers to healthcare access, including lack of insurance, transportation difficulties, and limited time off work. These barriers can exacerbate existing sleep disparities. Cultural stigmas surrounding mental health and sleep problems can prevent individuals from seeking help. The prevalence of shift work, common in lower-income occupations, further contributes to chronic sleep disruption.
The AASM survey doesn’t detail the funding sources for the research, but the organization itself receives funding from a variety of sources, including membership dues, educational programs, and industry partnerships. Transparency regarding funding is crucial to assess potential biases. But, the AASM’s commitment to evidence-based medicine and its rigorous accreditation standards for sleep centers provide a degree of assurance regarding the objectivity of its findings.
“We’ve known for some time that sleep is often the ‘forgotten pillar’ of health, alongside diet and exercise. This survey underscores the urgent need to integrate sleep health into routine medical care. It’s not enough to simply ask patients if they’re ‘sleeping okay.’ We need to proactively screen for sleep disorders and provide appropriate interventions.” – Dr. Nathaniel Watson, President of the AASM.
The impact of this communication gap extends to the regulatory landscape. The Food and Drug Administration (FDA) is currently evaluating several novel therapies for insomnia and sleep apnea, including digital therapeutics and advanced neuromodulation devices. [2] However, widespread adoption of these technologies hinges on increased awareness among both patients and healthcare providers. The European Medicines Agency (EMA) is similarly focused on evaluating the safety and efficacy of sleep-related medications, with a particular emphasis on minimizing the risk of dependence and adverse effects. The National Health Service (NHS) in the United Kingdom is implementing initiatives to improve access to sleep services, including cognitive behavioral therapy for insomnia (CBT-I), a first-line treatment recommended by the National Institute for Health and Care Excellence (NICE).
The underlying neurobiology of sleep is complex, involving a delicate interplay of neurotransmitters, hormones, and brain regions. The circadian rhythm, a roughly 24-hour internal clock regulated by the suprachiasmatic nucleus (SCN) in the hypothalamus, governs sleep-wake cycles. Disruptions to the circadian rhythm, caused by factors such as jet lag, shift work, or excessive screen time, can lead to sleep disturbances and a host of health problems. Melatonin, a hormone produced by the pineal gland, plays a crucial role in regulating sleep onset and duration. However, the efficacy of melatonin supplements remains a subject of debate, with studies yielding mixed results. [3]
| Sleep Disorder | Prevalence (US Adults) | Common Symptoms | Potential Health Risks |
|---|---|---|---|
| Insomnia | 30-35% | Difficulty falling asleep, staying asleep, or feeling rested | Depression, anxiety, cardiovascular disease |
| Sleep Apnea | 22 million Americans undiagnosed | Loud snoring, pauses in breathing during sleep, daytime sleepiness | Hypertension, stroke, diabetes |
| Restless Legs Syndrome (RLS) | 7-10% | Uncomfortable sensations in the legs, urge to move them | Iron deficiency, neurological disorders |
Contraindications & When to Consult a Doctor
While prioritizing sleep health is universally beneficial, certain populations require particular caution. Individuals with pre-existing psychiatric conditions should consult their psychiatrist before initiating any new sleep regimen, as some interventions may exacerbate symptoms. Patients with severe obstructive sleep apnea may require continuous positive airway pressure (CPAP) therapy, which has potential side effects such as nasal congestion and skin irritation. Pregnant women should avoid certain sleep medications and supplements without consulting their obstetrician.
Seek immediate medical attention if you experience:
- Sudden onset of severe sleepiness
- Difficulty breathing during sleep
- Chest pain or palpitations during sleep
- Unexplained daytime fatigue that interferes with daily activities
Looking ahead, the integration of sleep health into primary care settings is paramount. Healthcare providers need to be equipped with the tools and training to effectively screen for sleep disorders and provide evidence-based interventions. Public health campaigns aimed at raising awareness about the importance of sleep and destigmatizing sleep problems are also essential. Continued research is needed to unravel the complex neurobiology of sleep and develop more effective treatments for sleep disorders.
“The future of healthcare is preventative, and sleep is a cornerstone of preventative medicine. We need to shift the paradigm from treating sleep problems as a symptom to recognizing them as a potential cause of a wide range of health issues.” – Dr. Michael Twery, Director of the National Center on Sleep Disorders or Research at the National Heart, Lung, and Blood Institute (NHLBI).
References
- [1] Baker, F. C., et al. “Sleep and Women’s Health.” Sleep Medicine Reviews 58 (2021): 101531.
- [2] U.S. Food and Drug Administration. “Digital Health.” Accessed March 31, 2026.
- [3] Irwin, M. R., et al. “Melatonin and Sleep: A Critical Review.” Journal of Psychopharmacology 32.12 (2018): 1267-1289.
- American Academy of Sleep Medicine
- Centers for Disease Control and Prevention – Sleep
